Natural Alternatives (NAII) director granted 8,000 restricted shares

Rhea-AI Filing Summary

Dunn Alan G reported acquisition or exercise transactions in this Form 4 filing.

Natural Alternatives International director Alan G. Dunn received a grant of 8,000 shares of Common Stock as restricted stock under the company’s 2020 Omnibus Incentive Plan. One-third vests on March 7, 2027, another third on March 7, 2028, and the final third on March 7, 2029. Following this award, he directly holds 99,211 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Dunn Alan G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,000	$0.00	--

Holdings After Transaction: Common Stock — 99,211 shares (Direct)

Footnotes (1)

1. This transaction represents a grant of restricted stock to an outside Director pursuant to the Issuer's 2020 Omnibus Incentive Plan. One third (2,667 shares) of the restricted stock vests on March 7, 2027; one third (2,667 shares) of the restricted stock vests on March 7, 2028, and the final third (2,666 shares) of the restricted stock vests on March 7, 2029.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dunn Alan G

(Last) (First) (Middle)

1535 FARADAY AVENUE

(Street)

CARLSBAD CA 92008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATURAL ALTERNATIVES INTERNATIONAL INC [ NAII ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		A(1)		8,000(2)	A	$0	99,211	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction represents a grant of restricted stock to an outside Director pursuant to the Issuer's 2020 Omnibus Incentive Plan.

2. One third (2,667 shares) of the restricted stock vests on March 7, 2027; one third (2,667 shares) of the restricted stock vests on March 7, 2028, and the final third (2,666 shares) of the restricted stock vests on March 7, 2029.

	/s/ Alan G. Dunn By Kenneth E. Wolf Attorney in Fact	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NAII director Alan G. Dunn report?

Director Alan G. Dunn reported receiving 8,000 shares of NAII Common Stock as a restricted stock award. The grant was issued at no cash cost to him under the company’s 2020 Omnibus Incentive Plan as part of his director compensation.

How do the 8,000 restricted NAII shares vest for Alan G. Dunn?

The 8,000 restricted shares vest in three equal annual installments. 2,667 shares vest on March 7, 2027, another 2,667 on March 7, 2028, and the remaining 2,666 on March 7, 2029, assuming continued service as an outside director.

What is Alan G. Dunn’s NAII shareholding after this Form 4 grant?

After the restricted stock grant, Alan G. Dunn directly holds 99,211 shares of Natural Alternatives International Common Stock. This figure includes the newly awarded 8,000 restricted shares, which will vest over three years according to the disclosed schedule.

Was the NAII Form 4 transaction an open-market purchase or sale?

The transaction was not an open-market trade. It reflects a compensation-related grant of 8,000 restricted shares to an outside director, recorded with transaction code “A” for grant or award, at a reported price per share of $0.0000.

Under which plan were the 8,000 NAII restricted shares granted?

The 8,000 restricted shares were granted under Natural Alternatives International’s 2020 Omnibus Incentive Plan. This plan allows the company to issue equity-based awards, such as restricted stock, to directors and other eligible participants as part of their compensation.